Wintrust Investments LLC Edwards Lifesciences Corp Transaction History

Wintrust Investments LLC

$1.13 Billion
Q1 2024

A detailed history of Wintrust Investments LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wintrust Investments LLC holds 3,249 shares of EW stock, worth $295,918. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,249

Previous 17,979 81.93%

Holding current value

$295,918

Previous $1.37 Million 77.39%

% of portfolio

0.03%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $1.07 Million - $1.41 Million	-14,730 Reduced 81.93%	3,249 $310,000
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $153,472 - $193,389	2,487 Added 16.05%	17,979 $1.37 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $257,860 - $347,560	3,722 Added 31.62%	15,492 $1.07 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $59,836 - $69,332	735 Added 6.66%	11,770 $1.11 Million
Q1 2023 May 09, 2023	BUY	$74.26 - $84.51 $200,502 - $228,177	2,700 Added 32.39%	11,035 $912,000

Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $569,280 - $728,812	8,335 New	8,335 $622,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $451,097 - $668,928	-5,215 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $96,862 - $121,923	-950 Reduced 15.41%	5,215 $614,000
Q4 2021 Feb 04, 2022	SELL	$106.37 - $130.68 $36,165 - $44,431	-340 Reduced 5.23%	6,165 $799,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $20,067 - $23,936	-195 Reduced 2.91%	6,505 $736,000
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $19,702 - $24,618	-235 Reduced 3.39%	6,700 $694,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $545,645 - $628,796	6,935 New	6,935 $580,000
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $307,119 - $390,829	-4,284 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $22,105 - $28,767	329 Added 8.32%	4,284 $342,000
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $147,014 - $196,607	2,555 Added 182.5%	3,955 $273,000
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $20,439 - $31,590	390 Added 38.61%	1,400 $264,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3,585 - $4,104	-50 Reduced 4.72%	1,010 $236,000
Q3 2019 Nov 07, 2019	SELL	$61.55 - $75.43 $18,711 - $22,930	-304 Reduced 22.29%	1,060 $233,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $2,394 - $3,202	-50 Reduced 3.54%	1,364 $261,000
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $11,416 - $14,007	-246 Reduced 14.82%	1,414 $217,000
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $685 - $870	-15 Reduced 0.9%	1,660 $289,000
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $24,621 - $29,754	-580 Reduced 25.72%	1,675 $244,000
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $81,833 - $87,561	2,255	2,255 $246,000

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wintrust Investments LLC with notifications on news.

Account

Wintrust Investments LLC Edwards Lifesciences Corp Transaction History